Does luteal estradiol supplementation have a role in long agonist cycles?

Fertility and Sterility

Volumn 93, Issue 7, 2010, Pages 2182-2188

  Elgindy, Eman A ^a   El Haieg, Dahlia O ^a   Mostafa, Magdy I ^b   Shafiek, Mostafa ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Estradiol supplementation; GnRH agonist; ICSI cycles; Luteal phase support

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL VALERATE; ESTRADIOL VALERATE PLUS NORGESTREL; ESTROGEN; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN; DRUG DERIVATIVE; ESTRADIOL; FERTILITY PROMOTING AGENT; GONADORELIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG DOSE REDUCTION; EMBRYO TRANSFER; FEMALE; FOLLOW UP; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; MALE FACTOR INFERTILITY; MALE INFERTILITY; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; PRIVATE HOSPITAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; UNIVERSITY HOSPITAL; ALGORITHM; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG ADMINISTRATION ROUTE; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; FEMALE INFERTILITY; METHODOLOGY; MONITORING; MULTICENTER STUDY; OVULATION INDUCTION; PHYSIOLOGY;

ADULT; ALGORITHMS; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; LUTEAL PHASE; MONITORING, PHYSIOLOGIC; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROGESTERONE; SPERM INJECTIONS, INTRACYTOPLASMIC; YOUNG ADULT;

EID: 77952577624     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.01.066     Document Type: Article

References (25)

1. Pabuccua R, Akara ME. Luteal phase support in assisted reproductive technology. Curr Opin Obstet Gynecol 2005;17:277-81.
2. Pritts E, Atwood A. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 2002;17:2287-99.
3. 2 valerate supplementation in addition to intravaginal micronized progesterone in buser-elin and HMG induced superovulation. Hum Reprod 1993;8:40-5.
4. Lewin A, Benshushan A, Mezker E, Yanai N, Schenker JG, Goshen R. The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone support. Fertil Steril 1994;62:121-5.
5. Farhi J, Weissman A, Steinfeld Z, Shorer M, Nahum H, Levran D. Estra-diol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 2000;73:761-6.
6. Shetty G, Krishnamurthy H, Krishnamurthy HN, Bhatnagar S, Moudgal RN. Effect of estrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Mol Biol 1997;61: 157-66.
7. Sharara FI, McClamrock HD. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oes-tradiol concentration is predictive of in vitro fertilization outcome. Hum Reprod 1999;14:2777-82.
8. Kolibianakis EM, Venetis1 CA, Papanikolaou EG, Diedrich K, Tarlatzis BC, Griesinger G. Estrogen addition to progesterone for luteal phase support incycles stimulated with GnRH analogues and gonadotro-phinsfor IVF: a systematic review and meta-analysis. Hum Reprod 2008;23:1346-54.
9. Engmann L, Diluigi A, Schmidt D, Benadiva C, Maier D, Nulsen J. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. Fertil Steril 2008;89:554-61.
10. Fatemi HM, Kolibianakis EM, Camus M, Tournaye H, Donoso P, Papanikolaou E, et al. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Hum Reprod 2006;21:2628-32.
11. Ceyhan T, Basaran M, Duru NK, Goktolga U, Yilmaz A, Korkmaz C, et al. Use of luteal estrogen supplementation in normal responder patients treated with fixed multidose GnRH antagonist: a prospective randomized controlled study. Fertil Steril 2008;89:1827-30.
12. Serna J, Cholquevique JL, Villasante A, Oriol B, Requena A, Garcia-Velasco J. Adding estradiol patches to the luteal phase of IVI/ICSI cycles did not improve pregnancy nor miscarriage rates. Fertil Steril 2006;86: S73.
13. Lukaszuk K, Liss J, Lukaszuk M, Maj B. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 2005;83:1372-6.
14. Bulletti C, de Ziegler D, Flamigni C, Giacomucci E, Polli V, Bolelli G, et al. Targeted drug delivery in gynaecology: the first uterine pass effect. Hum Reprod 1997;12:1073-9.
15. Van Steirteghem AC, Nagy Z, Joris H, Liu J, Staessen C, Smitz J, et al. High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod 1993;7:1061-6.
16. Cicinelli E, De Ziegler D, Morgese S, Bulletti C, Luisi D, Schonauer LM. First uterine pass effect is observed when estradiol is placed in the upper but not lower third of the vagina. Fertil Steril 2004;81:1414-6.
17. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotrophins, re-combinant luteinizing hormone, or gonadotrophin releasing hormo-ne(GnRH)agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle stimulating hormone and GnRH antagonist cotreatment. J Clin Endocri-nol Metab 2003;88:4186-92.
18. Hutchinson-Williams KA, Lunenfeld B, Diamond MP, Lavy G, Boyers SP, DeCherney AH. Human chorionic gonadotrophins, estradiol, and progesterone profiles in conception and nonconception cycles in an in vitro fertilization program. Fertil Steril 1989;52:441-5.
19. Fatemi HM, Camus M, Kolibianakis EM, Tournaye H, Papanikolaou EG, Donoso P, et al. The luteal phase of recombinant follicle stimulating hor-mone/gonadotrophin releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. Fertil Steril 2007;87:504-8.
20. Paria BC, Lim H, Das SK, Reese J, Dey SK. Molecular signaling in uterine receptivity for implantation. Semin Cell Dev Biol 2000;11: 67-76.
21. de Ziegler D, Bouchard P. Understanding endometrial phisiology and menstrual disorders in 1990s. Curr Opin Obstet Gynecol 1993;5:378-88.
22. De Hertogh R, Vanderheyden I, Glorieux B, Ekka E. Estrogen and progesterone receptors in endometrium and myometrium at the time of blas-tocyst implantationin in pregnant diabetic rats. Diabetologia 1989;32: 568-72.
23. Fritz MA, Westfahl PK, Graham RL. The effect of luteal phase estrogen antagonist on endometrial development and luteal function in women. J Clin Endocrinol Metab 1987;65:1006-13.
24. Goldstein D, Zuckerman H, Harpaz S, Barkai J, Geva A, Gordon S, et al. Correlation between estradiol and progesterone in cycles with luteal phase deficiency. Fertil Steril 1982;37:348-54.
25. Wright KP, Guibert J, Weitzen S, Davy C, Fauque P, Olivennes F. Artificial versus stimulated cycles of endometrial preparation before frozen-thawed embryo transfer. Reprod Biomed 2006;13:321-5.